$ADMP americanbankingnews.com/201... Wall Street analysts expect that Adamis Pharmaceuticals Corp (NASDAQ:ADMP) will report $6.55 million in sales for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Adamis Pharmaceuticals’ earnings. The lowest sales estimate is $6.00 million and the highest is $7.10 million. Adamis Pharmaceuticals posted sales of $3.83 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 71%. The firm is scheduled to announce its next quarterly earnings results after the market closes on Tuesday, November 12th According to Zacks, analysts expect that Adamis Pharmaceuticals will report full year sales of $24.26 million for the current year, with estimates ranging from $22.00 million to $26.52 million.
View original message